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ABSTRACT
Introduction: Carbapenem-resistant Enterobacteriaceae (CRE), specially three species of the Enterobacteriaceae
family, the Klebsiella, Enterobacter and Escherichia have developed resistance to a group of antibiotics called
“Carbapenems”, which are often used as the last line of treatment when other antibiotics are not effective in
treating infections caused by them. Aim of the study: The present study was carried out to detect carbapenem
resistance profile  among Escherichia  coli & Klebsiella  pneumoniae. Materials &  Methods:  Cultures  were
obtained from consecutive specimens like urine, pus, sputum and blood collected from indoor as well as outdoor
patients of our hospital. Specimens were processed for culture and identification according to standard techniques.
Cultures  yielding  only Escherichia coli & Klebsiella  pneumoniae were included  in the study.  Antimicrobial
susceptibility testing was performed on Mueller-Hinton agar plates by the standard Kirby-Bauer disk diffusion
method  recommended by  CLSI  against  imipenem  and  meropem.  The  diameters  of  zone  of  inhibition  were
recorded as sensitive, resistant or intermediate sensitive according to the CLSI criteria. Results & Observations:
Total 206 isolates were surveyed. Urine & pus were the commonest specimens which isolated Escherichia coli &
Klebsiella  pneumoniae. 58.82%  & 8.82% E. coli were  resistant  to  meropenem  &  imipenem  respectively.
Similarly, 53.84% & 30.76% K. pneumoniae were resistant to meropenem & imipenem respectively. Conclusion:
K. pneumoniae and E. coli are commonly encountered pathogens from clinical specimens and exhibit resistance to
carbapenems. E. coli and K. pneumoniae isolates showed higher resistance to meropenem (58.82% and 53.84%,
respectively)  as  compared  to  imipenem  (8.82%  and  30.76%  respectively). K. pneumoniae shows  greater
resistance to carbapenems as compared to E. coli.
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INTRODUCTION
Gram  negative  bacilli  belonging  to  the
Enterobacteriaceae  are  the  most  frequently
encountered bacterial isolates recovered from clinical
specimens. Members of the Enterobacteriaceae may
be  associated  with  virtually  any  type  of  infectious
disease and recovered from any specimen received in
the  laboratory.  Microbiologist  must  be  alert  in  the
emergence  of  any  Enterobacteriaceae  that  are
resistant  to  multiple  antibiotics.  Detecting  these
resistant strains is not only important in treating the
patient from whom the isolate is recovered but also
has  important  implications  for  surveillance  of
nosocomial  infections.
1 Carbapenem-resistant
Enterobacteriaceae  (CRE),  specially,  the Klebsiella,
Enterobacter and Escherichia,  have  developed
resistance  to  a  group  of  antibiotics  called
“Carbapenems”, which are often used as the last line
of treatment when other antibiotics are not effective
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in treating infections caused by them.
2 Moreover, the
prevalence  of  carbapenem  resistance  in
Enterobacteriaceae  (CRE)  isolated  from  clinical
samples continues to increase throughout the world.
3
The present study was therefore carried out to detect
carbapenem resistance profile  among Escherichia
(E.) coli and Klebsiella (K.) pneumoniae.
MATERIALS AND METHODS
This  retrospective  study  was  carried  out with
clearance from institutional ethical committee, in the
bacteriology  laboratory  of  department  of
Microbiology,  of  Padmashree  Dr. Vitthalrao  Vikhe
Patil  Medical  College,  Ahmednagar,  Maharashtra.
The time period of this study was January 2012 to
January 2013.
Cultures were obtained from consecutive specimens
like  urine,  pus,  sputum  and  blood,  collected  from
indoor as well as outdoor patients from all clinical
departments of PDVVPF’s hospital, which is a 700
bed tertiary care hospital. Specimens were processed
for  culture  and  identification  according  to  standard
techniques.
1 Cultures yielding only Escherichia (E.)
coli and Klebsiella (K.) pneumoniae were included in
the study. All repeat isolates from the same patient
were excluded from the study irrespective of the type
of  specimen.  Antimicrobial  susceptibility  testing  of
isolates was performed on Mueller-Hinton agar plates
by the Kirby-Bauer  disk  diffusion  method
recommended  by  CLSI
4 against  imipenem
(10µg/disc)  and  meropenem  (10µg/disc). The
antibiotic  disc  of  imipenem  and  meropenem  were
purchased  from  Hi-Media  Laboratories  Pvt.  Ltd.
Mumbai,  Maharashtra. The growth  inhibition  zone
diameter was  recorded  and  interpreted  as  sensitive
(Imipenem  &  Meropenem  is ≥  16  mm), resistant
(Imipenem  &  Meropenem  is ≤  13  mm),  or
intermediate sensitive (Imipenem & Meropenem is 14
mm), by the criteria of CLSI.
4 Intermediate sensitive
isolates  were included in resistant  isolates  for final
analysis. Strain of E. coli ATCC 25922 was used as
control.
RESULTS
A  total  of  206  isolates  were  surveyed. Table  1
Indicates  details  of  type  of  specimens  from which
isolates were obtained. Resistance pattern of E. coli to
meropenem  and  imipenem,  where  total  isolates of
Escherichia coli are 102. Table  no.  2,  3 shows
resistance  pattern  of Klebsiella  pneumoniae to
meropenem and imipenem, where total isolates of K.
pneumoniae are 104.
Table 1: Details of type of specimens from which isolates were obtained
Sr. no. Specimen E. coli n (%) K. pneumoniae n (%) Total = n
1 Urine 46 (54.76) 38 (45.23) 84
2 Pus 47 (55.95) 37 (44.04) 84
3 Sputum 07 (24.13) 22 (75.86) 29
4 Blood 02 (22.22) 07 (77.77) 09
5 Total 102 104 206
Table 2: Resistance pattern of Escherichia coli (n=102) to meropenem and imipenem.
Sr. no. Specimen(n) Meropenem n (%) Imipenem n (%) Both n (%)
1 Urine(46) 25 (54.34) 04 (8.69) 04 (8.69)
2 Pus(47) 27 (57.44) 05 (10.63) 02 (4.25)
3 Sputum(7) 06 (85.71) 00 (00) 00 (00)
4 Blood(2) 02 (100 ) 00 (00) 00 (00)
5 Total(102) 60(58.82) 09(8.82) 06(5.88)
Table 3: Resistance pattern of Klebsiella pneumoniae (n=104) to meropenem and imipenem.
Sr. no. Specimen (n) Meropenem n (%) Imipenem n (%) Both n (%)
1 Urine(38) 23 (60.52) 12 (31.57) 09 (23.68)
2 Pus(37) 19 (51.35) 09 (24.32) 06 (16.21)
3 Sputum(22) 08 (36.36) 08 (36.36) 06 (27.27)
4 Blood(7) 06 (85.71) 03 (42.85) 02 (28.57)
5 Total(104) 56(53.84) 32(30.76) 23(22.11)426
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DISCUSSION
Urine  and  pus  were  the  most  common  specimens
which isolated E. coli and K. pneumoniae. Out of the
total 206 isolates 84(40.77%) each were E. coli and
K. pneumoniae,  followed  by  14.07%  isolates  from
sputum and 4.36% isolates from blood. This is well in
accordance with Nagaraj S et al.
5 who also reported
42%  carbapenem  isolates  of E. coli and K.
pneumoniae from  urine.  Parveen  RM
6 reported
37.86% isolates of K. pneumoniae from urine.
Out  of  102  isolates  of E. coli,  60(58.82%)  were
resistant to meropenem. Nagaraj S et al.
5 reported
higher resistance of 80% of E. coli to meropenem.
Out of 102 isolates of E. coli 9(8.82%) were resistant
to imipenem. These findings are quite similar to Datta
S et al.
7, who reported 6% isolates of E. coli resistant
to imipenem.
As far as K. pneumoniae is concerned 56(53.84%) out
of 104 isolates were resistant to meropenem. This is
fairly  in  accordance  with  Parveen  RM et  al.
6 who
reported  43.6% K. pneumoniae isolates  resistant  to
meropenem. On the other hand these findings are low
as  compared  to  Nagaraj  S et  al.
5 who  reported
29(80.55%)  out  of  36  isolates  of K. pneumoniae
resistant to meropenem, whereas, are extremely high
as  compared  to  Bora  A et  al.
8 who  reported  19
(9.22%)  out  of  206 isolates  of K. pneumoniae
resistant  to  meropenem  and  imipenem. Out  of  104
isolates of k. pneumoniae, 32 (30.76%) were resistant
to imipenem, which is well in accordance to Parveen
RM et  al.  (6),  who    reported  32%  isolates  of K.
pneumoniae resistant  to  imipenem  &  varies  from
Datta S et al.
7, who reported 52 % resistant isolates.
Finally,  5.88% E. coli &  22.11% K. pneumoniae
isolates  were  resistant  to  both  meropenem  and
imipenem. K. pneumoniae exhibits greater resistance
to carbapenems.
Carbapenems are one of the important antibiotics in
the  treatment  of  serious  infections  caused  by
members  of  the  family  Enterobacteriaceae.
9 High
level of carbapenem resistance in K. pneumoniae is
due  to  combination  of  different  factors  like  β-
lactamase production, porin OmpK 35/36 Insertional
inactivation  and  down-regulation  of  the  phosphate
transport  porin  and  changes in  penicillin-binding
proteins.
10
Resistance in K. pneumoniae mediated  by K.
pneumoniae carbapenemase  (KPC)  can  accompany
other  Gram  negative  resistance  mechanisms.  The
genes  of  which  enzymes  are  usually  present  on
plasmids and hence can spread easily.
11
This makes it important to constantly keep a check on
the prevalence of  resistance  to  antibiotics  in
commonly encountered pathogens. The present study
was conducted keeping this concept in mind.
In the era of molecular approaches for the study of
genes  which  mediate  carbapenem  resistance,  the
present survey serves as a pilot study. Also it inspires
us to carry out further extensive research in view of
drug  resistance  periodically  which  may  include  the
ICU and the non-ICU sections, demographic aspects,
clinical aspects etc.
CONCLUSION
K. pneumoniae and E. coli are  commonly
encountered pathogens from clinical specimens and
exhibit  resistance  to  carbapenems. E. coli and K.
pneumoniae isolates  show  higher  resistance  to
meropenem  (58.82%  and  53.84%  respectively)  as
compared  to  imipenem  (8.82%  and  30.76%
respectively). Imipenem shows better sensitivity in-
vitro  as  compared  to  meropenem. K. pneumoniae
shows greater resistance to carbapenems as compared
to E. coli. This emerging resistance may an alarming
situation  and  indicates need  of judicious  use  of
antibiotics  and  keeping  a  constant  check  on
susceptibility of pathogens to various antimicrobials
including the carbapenems. So that, should the need
arise,  methods  can  be  implemented  to  control  the
spread  of  such  resistant  strains  in  the  hospital
environment.  Also it  gives  an  insight  to  carry  out
more extensive research.
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